APP and Alzheimer disease: In a study from Virginia Lee’s group, human brain-derived pathological tau (AD-tau) was injected into two Aβ mouse models, 5xFAD, and APP KI mice which express human APP carrying the Swedish double mutation under control of the murine APP promotor at different stages of Aβ deposition [69].